ストックスクリーナーアプリを入手
3.53
4.85%
-0.18
アフターアワーズ：
3.53
前日終値:
$3.71
開ける：
$3.71
24時間の取引高:
274.83K
Relative Volume:
0.53
時価総額：
$1.10B
収益：
$563.46M
当期純損益:
$27.92M
株価収益率:
36.62
EPS:
0.0964
ネットキャッシュフロー:
$-146.33M
1週間 パフォーマンス:
+4.13%
1か月 パフォーマンス:
+1.73%
6か月 パフォーマンス:
-58.47%
1年 パフォーマンス:
-58.62%
1日の値動き範囲:
$3.51
$3.78
1週間の範囲:
$3.42
$3.78
52週間の値動き範囲:
$3.03
$11.85
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
3.53 | 1.13B | 563.46M | 27.92M | -146.33M | 0.0964 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Underweight |
| 2025-11-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-10-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 開始されました | UBS | Buy |
| 2024-01-29 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | アップグレード | Citigroup | Sell → Neutral |
| 2023-09-21 | 開始されました | Barclays | Equal Weight |
| 2022-09-07 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-09-06 | ダウングレード | Citigroup | Buy → Sell |
| 2022-07-26 | 開始されました | Citigroup | Buy |
すべてを表示
Alvotech (ALVO) 最新ニュース
Cash per share of Alvotech – DUS:Z45 - TradingView — Track All Markets
ALVO SEC FilingsAlvotech 10-K, 10-Q, 8-K Forms - Stock Titan
ALVO Technical Analysis & Stock Price Forecast - Intellectia AI
Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO) - Seeking Alpha
Retail Trends: Whats the outlook for Alvotech Equity Warrants sector2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Alvotech’s Price Rises But Technical Signals Turn Bearish - Bitget
Performance Recap: Is Alvotech a top pick in the sector2026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
Why Is Alvotech (ALVOW) Stock Down Today? - Meyka
Alvotech stock: Biosimilar innovator with global growth potential - AD HOC NEWS
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Alvotech (NASDAQ:ALVO) Stock Price Down 9.5%Here's What Happened - MarketBeat
Alvotech Plummets 9.5% Amid Market Volatility and Sector Uncertainty - Bitget
Alvotech CCO Anil Okay steps down to become Adalvo CEO - MSN
Published on: 2026-04-07 05:57:03 - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Trading Up 7.2%Here's What Happened - MarketBeat
ETFs Investing in Alvotech Stocks - TradingView
Institution Moves: Is Alvotech stock overvalued or fairly pricedMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Stock Rating Lowered by Wall Street Zen - MarketBeat
ALVO Should I Buy - Intellectia AI
ALVO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag - MSN
Alvotech (ALVO) revenue surges 21% year-over-year in 2025 - MSN
ALVO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Alvotech Earnings Call: Growth Momentum Meets FDA Risk - The Globe and Mail
Alvotech (ALVO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alvotech (ALVO) Revenue Surges 21% Year-Over-Year in 2025 - Insider Monkey
Does Alvotech’s (ALVO) Reaffirmed 2026 Revenue Target Redefine Its Biosimilar Strategy Narrative? - Sahm
Alvotech’s comprehensive biosimilars platform presents an uneven risk-reward profile as the market factors in the FDA approval challenge - Bitget
Alvotech : Transactions of Managers and Closely Associated Persons - marketscreener.com
Alvotech : Managers’ transactionsManager Transaction NotificationATP ehf.EN - marketscreener.com
Alvotech : Managers' transactionsALVOTECH - MarketScreener
Alvotech Files Annual Report 2025 with the U.S. SEC - Quiver Quantitative
Alvotech Files Annual Report with the SEC - The Manila Times
Alvotech files Annual Report with the SEC - GlobeNewswire
Alvotech Publishes 2025 Annual Report - GlobeNewswire
Alvotech (NASDAQ: ALVO) turns 2025 profit while managing heavy debt and FDA CRLs - Stock Titan
Alvotech (NASDAQ:ALVO) Shares Up 5.3%Time to Buy? - MarketBeat
Short Interest in Alvotech (NASDAQ:ALVO) Drops By 17.0% - MarketBeat
Alvotech Stock: Biosimilar Innovator Positions for U.S. Market Expansion Amid Global Growth Push - AD HOC NEWS
Alvotech (NASDAQ:ALVO) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alvotech Faces Weak Start with 6.54% Gap Down Amid Market Concerns - Markets Mojo
Retail Trends: What is the dividend yield of Alvotech Equity WarrantMarket Rally & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Fed Meeting: Whats the fair value of Alvotech stock2026 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
Statutory Earnings May Not Be The Best Way To Understand Alvotech's (NASDAQ:ALVO) True Position - Yahoo Finance
Alvotech Shares Plunge to New 52-Week Low at $3.03 - Markets Mojo
Alvotech stock hits new 52-week low on UBS price target cut to $6 amid biosimilar launch delays - AD HOC NEWS
Alvotech (NASDAQ:ALVO) Sets New 12-Month Low After Analyst Downgrade - MarketBeat
Alvotech price target lowered to $4 from $5 at Barclays - TipRanks
Alvotech Drops 14% Amid Prevailing Negative Market Sentiment - Bitget
Alvotech price target lowered to $4 from $8 at Deutsche Bank - TipRanks
Alvotech (ALVO) 財務データ
収益
当期純利益
現金流量
EPS
1.06%
1.05%
大文字化:
|
ボリューム (24 時間):